This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

5th TPD and Induced Proximity Summit Europe

181 181 people viewed this event.

Induced proximity medicines are revolutionising therapeutic strategies, offering groundbreaking solutions for disease treatment.

In 2024 alone, PhoreMost secured $50 million in Series B financing for its degrader programs, while Merck KGaA partnered with C4 Therapeutics in a $756 million deal focused on protein degraders.

 

Time: 9:00 AM – 5:00 PM

Venue details: 15Hatfields, Chadwick Court, London, England, SE1 8DJ, United Kingdom

Prices: GBP 1699.00 – GBP 5196.00

Speakers: Alexandros Patsilinakos, Head of Medicinal Chemistry, Sibylla Biotech, Andrea Testa, Senior Director Discovery Chemistry, Amphista Therapeutics, Andreas Mantoulidis, Research Laboratory Head, Boehringer Ingelheim, Andrew Potterton, Chief Technology Officer, Ternary Therapeutics, and more

Event Organizer - Hanson Wade

Email - info@hansonwade.com

Event Website
 

Date

25–27 March 2025
 

City

 

Country

United Kingdom
 

Topic Area

Health and Medicine

Share With Colleagues